AbbVie to Bolster its Immunology Pipeline Through the Acquisition of Nimble Therapeutics
Shots: AbbVie has signed a definitive agreement to acquire Nimble Therapeutics for...
Roche to Acquire Poseida Therapeutics for ~$1.5B
Shots: Roche will acquire Poseida for $9/share in cash, strengthening its CAR-T th...
Novartis Reports the Acquisition of Kate Therapeutics for ~$1.1B
Shots Novartis has agreed to acquire Kate Therapeutics, strengthening its portfoli...
BioNTech to Acquire Biotheus, Enhancing its R&D Capabilities in Oncology and Expanding Reach Across China
Shots: The acquisition will enhance BioNTech's capabilities in development, ma...
Kalaris Therapeutics Reverse Merges with AlloVir to Advance Therapies Focusing on Retinal Diseases
Shots: Allovir will acquire 100% outstanding shares of Kalaris, forming a combined...
GHO Capital Partners and Ampersand Capital Partners Report the Acquisition of Avid Bioservices for ~$1.1B
Shots: GHO Capital Partners and Ampersand Capital Partners have agreed to acquire...
